Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalities

Future Oncol. 2020 May;16(14):955-960. doi: 10.2217/fon-2020-0067. Epub 2020 Apr 17.

Abstract

Aim: To explore management trends in preinvasive and cT1-T3 penile cancer. Materials & methods: The National Cancer Database was queried (2004-2013) for cT1-T3 M0 penile cancer with specified nonpalliative surgical techniques and histologies (n = 5,728). Results: Local excision (39%) and partial penectomy (38%) were most commonly utilized. Patients with cTis/Ta or cT1 disease more often received nonpenectomy approaches (p < 0.05); cT2-T3 cases more likely underwent penectomy (p < 0.001). No survival differences were observed between penectomy (49.3 months) and nonpenectomy approaches (50.3 months) in the overall cohort (p = 0.107) and when stratifying by T-stage (p > 0.20 for all). Conclusion: This study provides contemporary insight into the landscape for management of this rare disease and can serve as a benchmark for future evaluation of treatment trends.

Keywords: NCCN guidelines; National Cancer Database; penectomy; penile cancer; wide local excision.

MeSH terms

  • Combined Modality Therapy / adverse effects
  • Combined Modality Therapy / methods
  • Disease Management
  • Humans
  • Male
  • Neoplasm Staging
  • Penile Neoplasms / diagnosis
  • Penile Neoplasms / epidemiology
  • Penile Neoplasms / therapy*
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome